Wockhardt Beheer

Beheer criteriumcontroles 4/4

De CEO Wockhardt is Murtaza Khorakiwala, benoemd in Apr2009, heeft een ambtstermijn van 15.58 jaar. De totale jaarlijkse vergoeding van { bedraagt ₹ 21.20M, bestaande uit 95.3% salaris en 4.7% bonussen, inclusief aandelen en opties van het bedrijf. bezit rechtstreeks 0.18% van de aandelen van het bedrijf, ter waarde ₹ 362.69M. De gemiddelde ambtstermijn van het managementteam en de raad van bestuur bedraagt respectievelijk 15.6 jaar en 7.5 jaar.

Belangrijke informatie

Murtaza Khorakiwala

Algemeen directeur

₹21.2m

Totale compensatie

Percentage CEO-salaris	95.3%
Dienstverband CEO	15.6yrs
Eigendom CEO	0.2%
Management gemiddelde ambtstermijn	15.6yrs
Gemiddelde ambtstermijn bestuur	7.5yrs

Recente managementupdates

Recent updates

Analyse CEO-vergoeding

Hoe is Murtaza Khorakiwala's beloning veranderd ten opzichte van Wockhardt's winst?
Datum	Totale vergoeding	Salaris	Bedrijfswinsten
Sep 30 2024	n/a	n/a	-₹3b
Jun 30 2024	n/a	n/a	-₹3b
Mar 31 2024	₹21m	₹20m	-₹5b
Dec 31 2023	n/a	n/a	-₹5b
Sep 30 2023	n/a	n/a	-₹5b
Jun 30 2023	n/a	n/a	-₹6b
Mar 31 2023	₹24m	₹23m	-₹6b
Dec 31 2022	n/a	n/a	-₹6b
Sep 30 2022	n/a	n/a	-₹5b
Jun 30 2022	n/a	n/a	-₹3b
Mar 31 2022	₹24m	₹17m	-₹2b
Dec 31 2021	n/a	n/a	-₹787m
Sep 30 2021	n/a	n/a	-₹567m
Jun 30 2021	n/a	n/a	-₹867m
Mar 31 2021	₹24m	₹24m	-₹3b
Dec 31 2020	n/a	n/a	-₹2b
Sep 30 2020	n/a	n/a	-₹3b
Jun 30 2020	n/a	n/a	-₹3b
Mar 31 2020	₹24m	₹24m	-₹2b
Dec 31 2019	n/a	n/a	-₹1b
Sep 30 2019	n/a	n/a	-₹2b
Jun 30 2019	n/a	n/a	-₹2b
Mar 31 2019	₹24m	₹24m	-₹3b
Dec 31 2018	n/a	n/a	-₹3b
Sep 30 2018	n/a	n/a	-₹3b
Jun 30 2018	n/a	n/a	-₹3b
Mar 31 2018	₹24m	₹19m	-₹6b

Compensatie versus markt: De totale vergoeding ($USD 251.05K ) Murtaza } ligt onder het gemiddelde voor bedrijven van vergelijkbare omvang in de Indian markt ($USD 481.61K ).

Compensatie versus inkomsten: De vergoeding van Murtaza is het afgelopen jaar in lijn geweest met de bedrijfsprestaties.

CEO

Murtaza Khorakiwala (51 yo)

15.6yrs

Tenure

₹21,200,000

Compensatie

Dr. Murtaza Habil Khorakiwala serves as the Managing Director of Wockhardt Ltd. since April 2009 and has been its Executive Director since March 31, 2009. Dr. Khorakiwala serves as a Director of Khorakiwal...

Leiderschapsteam

Naam	Positie	Tenure	Compensatie	Eigendom
Habil Khorakiwala	Founder & Executive Chairman	20.8yrs	₹36.50m	0.37% ₹ 736.7m
Murtaza Khorakiwala	MD & Executive Director	15.6yrs	₹21.20m	0.18% ₹ 362.7m
Huzaifa Khorakiwala	Executive Director	15.6yrs	₹21.20m	0.17% ₹ 346.3m
Deepak Madnani	Chief Financial Officer	2.4yrs	geen gegevens	0.0080% ₹ 16.0m
Mahesh Patel	Chief Scientific Officer of New Drug Discovery	no data	₹1.71m	0.036% ₹ 71.9m
Debolina Partap	Senior Vice President of Legal	no data	geen gegevens	0.0077% ₹ 15.5m
Neeraj Agarwal	Chief Human Resource Officer	no data	geen gegevens	geen gegevens
Anil Kamath	Senior Vice President of Business Development	no data	₹1.61m	geen gegevens
Zoher Sihorwala	Head of Global Regulatory Affairs	10.8yrs	geen gegevens	geen gegevens
Prakash Gupta	President of Supply Chain	no data	geen gegevens	geen gegevens
Ravindra Limaye	Managing Director of Wockhardt UK	no data	geen gegevens	geen gegevens
Lalit Aggarwal	President of Manufacturing	no data	geen gegevens	geen gegevens

15.6yrs

Gemiddelde duur

57yo

Gemiddelde leeftijd

Ervaren management: Het managementteam van 532300 is doorgewinterd en ervaren (gemiddelde ambtstermijn van 15.6 jaar).

Bestuursleden

Naam	Positie	Tenure	Compensatie	Eigendom
Habil Khorakiwala	Founder & Executive Chairman	20.8yrs	₹36.50m	0.37% ₹ 736.7m
Murtaza Khorakiwala	MD & Executive Director	15.7yrs	₹21.20m	0.18% ₹ 362.7m
Huzaifa Khorakiwala	Executive Director	15.6yrs	₹21.20m	0.17% ₹ 346.3m
Akhilesh Krishna Gupta	Non-Executive Independent Director	4.3yrs	₹1.10m	geen gegevens
Vinesh Jairath	Non-Executive & Independent Director	8yrs	₹1.70m	geen gegevens
Zahabiya Khorakiwala	Non-Executive Non- Independent Director	7.1yrs	₹300.00k	geen gegevens
Ahmad Javed	Non Executive Independent Director	less than a year	geen gegevens	0.00012% ₹ 240.5k
Amelia Fernandes	Independent Director	1.3yrs	₹1.00m	0.000060% ₹ 120.2k

7.5yrs

Gemiddelde duur

66.5yo

Gemiddelde leeftijd

Ervaren bestuur: De raad van bestuur van 532300 wordt beschouwd als ervaren (gemiddelde ambtstermijn 7.5 jaar).

Wockhardt Beheer

Beheer criteriumcontroles 4/4

Belangrijke informatie

Recente managementupdates

Wockhardt Limited, Annual General Meeting, Jun 28, 2024

Wockhardt Limited Appoints Ahmad Javed as Additional (Independent) Director

Wockhardt Limited Announces Cessation of Independent Directors

Insufficient new directors

Wockhardt Limited, Annual General Meeting, Aug 14, 2023

Insufficient new directors

Recent updates

Second quarter 2025 earnings released: ₹1.47 loss per share (vs ₹5.37 loss in 2Q 2024)

Wockhardt Limited to Report First Half, 2025 Results on Nov 13, 2024

Wockhardt Limited has filed a Follow-on Equity Offering.

Wockhardt's Miqnaf (Nafithromycin) Receives Favourable Recommendation from Subject Expert Committee of Central Drugs Standard Control Organization

Wockhardt's WCK 6777 Receives Fast Track Designation by US FDA, Completes Phase I Study

First quarter 2025 earnings released: ₹0.95 loss per share (vs ₹9.28 loss in 1Q 2024)

Wockhardt Limited to Report Q1, 2025 Results on Aug 09, 2024

Wockhardt Limited, Annual General Meeting, Jun 28, 2024

Wockhardt Limited Appoints Ahmad Javed as Additional (Independent) Director

Full year 2024 earnings released: ₹32.05 loss per share (vs ₹38.80 loss in FY 2023)

Wockhardt Limited to Report Q4, 2024 Results on May 28, 2024

Wockhardt Limited Announces Cessation of Independent Directors

Wockhardt Limited has completed a Follow-on Equity Offering in the amount of INR 4.800429 billion.

New minor risk - Shareholder dilution

Wockhardt Limited has filed a Follow-on Equity Offering.

Wockhardt Limited has filed a Follow-on Equity Offering.

Third quarter 2024 earnings released: ₹5.75 loss per share (vs ₹6.62 loss in 3Q 2023)

New minor risk - Share price stability

Second quarter 2024 earnings released: ₹5.37 loss per share (vs ₹13.15 loss in 2Q 2023)

Insufficient new directors

Wockhardt Limited to Report Q1, 2024 Results on Aug 14, 2023

Wockhardt Limited, Annual General Meeting, Aug 14, 2023

Wockhardt Limited to Report Q4, 2023 Results on May 26, 2023

Third quarter 2023 earnings released: ₹6.62 loss per share (vs ₹0.61 loss in 3Q 2022)

Wockhardt Limited to Report Q3, 2023 Results on Feb 13, 2023

Insufficient new directors

Second quarter 2023 earnings released: ₹13.15 loss per share (vs ₹3.03 profit in 2Q 2022)

Wockhardt Announces Successful Initiation of Global Phase 3 Clinical Study of Its Novel Antibiotic WCK 5222

Wockhardt Limited to Report Q1, 2023 Results on Aug 12, 2022

Wockhardt Limited, Annual General Meeting, Aug 12, 2022

Wockhardt Limited Announces Chief Financial Officer Changes

Full year 2022 earnings released

Insufficient new directors

Wockhardt Limited to Report Q4, 2022 Results on May 30, 2022

Wockhardt Limited Announces Chief Financial Officer Changes

Wockhardt Gets CDSCO Nod for Exporting Up to 100 Million Doses of Sputnik Vaccines

Third quarter 2022 earnings: EPS in line with expectations, revenues disappoint

Second quarter 2022 earnings released: EPS ₹3.03 (vs ₹0.32 in 2Q 2021)

Board Member recently bought ₹4.4m worth of stock

Company Secretary & Compliance Officer Gajanand Sahu has left the company

Full year 2021 earnings released: ₹27.02 loss per share (vs ₹14.79 loss in FY 2020)

Insider recently sold ₹20m worth of stock

Full year 2021 earnings released: ₹27.02 loss per share (vs ₹14.79 loss in FY 2020)

UK Government Announces Covid-19 Vaccination Contract Extension with Wockhardt

Third quarter 2021 earnings released: EPS ₹1.38 (vs ₹0.87 in 3Q 2020)

Wockhardt Limited to Report Q3, 2021 Results on Jan 29, 2021

New 90-day high: ₹551

Insider recently sold ₹1.6m worth of stock

New 90-day high: ₹487

New 90-day high: ₹393

First quarter earnings released

Wockhardt Limited to Report Q1, 2021 Results on Aug 29, 2020

New 90-day high - ₹303

Analyse CEO-vergoeding

CEO

Tenure

Compensatie

Leiderschapsteam

Gemiddelde duur

Gemiddelde leeftijd

Bestuursleden

Gemiddelde duur

Gemiddelde leeftijd